HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹280 Cr | ₹187 Cr | ₹315 Cr | ₹294 Cr | ₹229 Cr |
What is the latest Cash Flow from Operating Activities ratio of HIKAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹280 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹315 Cr |
| Mar2022 | ₹294 Cr |
| Mar2021 | ₹229 Cr |
How is Cash Flow from Operating Activities of HIKAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹280 Cr | 50.19 | |
| Mar2024 | ₹187 Cr | -40.79 | |
| Mar2023 | ₹315 Cr | 7.35 | |
| Mar2022 | ₹294 Cr | 28.26 | |
| Mar2021 | ₹229 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,622.6 Cr | -2.4% | -7.1% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.4% |
-7.1% |
-24.9% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses